Espoo, Finland (ots/PRNewswire) - Negotiations have been completed with the personnel representatives in Orion Diagnostica Oy, a subsidiary of Orion Corporation, concerning operational rearrangements at Orion Diagnostica's sites in Finland. As a result of the negotiations, a decision has been made to transfer the production operations of the Oulunsalo plant to Turku. There are 30 employees at the Oulunsalo site. ...
Espoo, Finland (ots/PRNewswire) - Net sales of the Orion Group were EUR 465.3 (496.9) million, down by 6.4% due to decreased invoicing of the pharmaceutical distribution business. Group operating profit grew by 52.2% to EUR 50.8 (33.4) million, thanks to the favourable performance of Orion Pharma. Group profit before taxes was EUR 50.6 (33.0) million. Earnings per share were EUR 0.27 (0.17). Equity ratio was 40.7% ...
Espoo, Finland (ots/PRNewswire) - The operating profit of the Orion Group for the first quarter of 2005 seems to be clearly better than that in the comparative period last year, for which the consolidated operating profit in accordance with the IFRS came to EUR 33.4 million. The good profitability is mainly consequence of the continued good sales performance and successful cost management in the Orion Pharma business division. Also the full-year net sales and ...
Espoo, Finland (ots/PRNewswire) - At its meeting held yesterday evening, the Board of Directors of Orion Corporation, which was elected yesterday at the Annual General Meeting of Shareholders, has re-elected Erkki Etola as Vice Chairman. Orion Corporation Jukka Viinanen Olli Huotari President and CEO General Counsel ...
Espoo, Finland (ots/PRNewswire) - At the Annual General Meeting of Orion Corporation held today, the following decisions were made: - A dividend of EUR 0.55 per share will be paid for 2004, payment date 5 April 2005. - Seven Board members were elected in accordance with the proposal by Board of Directors. Erkki Etola, Eero Karvonen, Matti Kavetvuo, Leena Palotie, Vesa Puttonen and Heikki Vapaatalo were ...
Espoo, Finland (ots/PRNewswire) - In his presentation of the 2004 Financial Statements to the Annual General Meeting of Orion Corporation, starting at 5 pm today in Helsinki, Mr. Jukka Viinanen, CEO of the Orion Group, will inform that the profitability of the Orion Group has shown very positive development in the first months of 2005 compared to the corresponding ...
Espoo, Finland (ots/PRNewswire) - - Parkinson's Patients who Require the Start of Levodopa Therapy may be Eligible to Participate in This Study Orion Pharma and Novartis announced that they are launching STRIDE-PD (STalevo Reduction In Dyskinesia Evaluation). This major study in Parkinson's disease (PD) ...